Stanley Lipschitz

Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis

Steven Boonen, Jean‐Yves Reginster, Jean‐Marc Kaufman et al. · New England Journal of Medicine · 2012 · 347 citations · Full text

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 164 citations

Bone Disease, Osteopathy, Loft Extension Study +10

Subcutaneous Fluid Administration in Elderly Subjects: Validation of an Under‐Used Technique

Stanley Lipschitz, A. J. Campbell, Michael S. Roberts et al. · Journal of the American Geriatrics Society · 1991 · 89 citations

Elderly Subjects, Under‐used Technique, Geriatric Anesthesia +16

Upper gastrointestinal and overall tolerability of alendronate once weekly in patients with osteoporosis: results of a randomized, double-blind, placebo-controlled study

John A. Eisman, René Rizzoli, JA Román-Ivorra et al. · Current Medical Research and Opinion · 2004 · 38 citations

Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer’s Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study

Hana Florian, Andreas Meier, Serge Gauthier et al. · Journal of Alzheimer s Disease · 2016 · 34 citations